Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137331243> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2137331243 abstract "BACKGROUND: Glioblastomas (GBMs), the most common and malignant primary brain tumors, always recur after standard treatment. In order to develop more efficient therapies, we tested a novel therapeutic approach using the radioactive Auger-electron-emitter (AEE) [125I]5-Iodo-2'-deoxyuridine (125I-UdR). This drug incorporates into DNA of dividing cells and upon decay emission of Auger-electrons causes clusters of double strand breaks leading to cell death. METHODS: In vitro, cells from two GBM spheroid cultures (T78 & T87) were exposed to either 125I-UdR or 127I-UdR (non-radioactive analogue) and tumor cell viability and migration were measured. In vivo, nude rats were implanted orthotopically with T87 cells and after tumor formation micro infusion pumps were implanted enabling direct intratumoral convection-enhanced delivery (CED). Animals were divided into three groups (I-III). Group I (n = 8) was treated with 127I-UdR by CED, group II (n = 7) with neoadjuvant methotrexate (MTX) + 125I-UdR by CED and group III with neoadjuvant MTX + 125I-UdR by CED and concomitant systemic temozolomide (TMZ). Rats were followed for 180 days post-treatment with repeated [11C]methylaminoisobutyric acid ([11C]MeAIB) positron emission tomography scans and blood sampling. Single photon emission computed tomography/computed tomography (SPECT/CT) scans were performed to evaluate 125I-UdR distribution. Additionally, post-mortem histological examination of brain, liver, kidneys and thyroid gland was performed. RESULTS: In vitro, 125I-UdR significantly decreased GBM cell viability and migration. In group I, no animals (8/8) survived longer than 23 days after treatment start. In group II, 4/7 animals survived the entire observation period of 180 days. In group III, all animals (8/8) survived the entire observation period. SPECT/CT showed a widespread intracerebral distribution of 125I-UdR, while blood samples and post-mortem histology revealed no signs of dose-limiting adverse effects. CONCLUSIONS: The novel therapeutic approach with CED of MTX and the AEE-compound 125I-UdR in combination with systemic TMZ seemed safe and very efficient in the orthotopic GBM model." @default.
- W2137331243 created "2016-06-24" @default.
- W2137331243 creator A5003637098 @default.
- W2137331243 creator A5016873693 @default.
- W2137331243 creator A5023573690 @default.
- W2137331243 creator A5029139222 @default.
- W2137331243 creator A5041544624 @default.
- W2137331243 creator A5077466227 @default.
- W2137331243 creator A5081845117 @default.
- W2137331243 creator A5085481487 @default.
- W2137331243 creator A5086266747 @default.
- W2137331243 creator A5090217514 @default.
- W2137331243 date "2014-11-01" @default.
- W2137331243 modified "2023-10-16" @default.
- W2137331243 title "ET-22 * CONVECTION-ENHANCED DELIVERY OF THE AUGER-ELECTRON-EMITTER 125I-UdR: A HIGHLY EFFICIENT THERAPY IN AN ORTHOTOPIC GLIOBLASTOMA XENOGRAFT MODEL" @default.
- W2137331243 doi "https://doi.org/10.1093/neuonc/nou255.22" @default.
- W2137331243 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4218118" @default.
- W2137331243 hasPublicationYear "2014" @default.
- W2137331243 type Work @default.
- W2137331243 sameAs 2137331243 @default.
- W2137331243 citedByCount "0" @default.
- W2137331243 crossrefType "journal-article" @default.
- W2137331243 hasAuthorship W2137331243A5003637098 @default.
- W2137331243 hasAuthorship W2137331243A5016873693 @default.
- W2137331243 hasAuthorship W2137331243A5023573690 @default.
- W2137331243 hasAuthorship W2137331243A5029139222 @default.
- W2137331243 hasAuthorship W2137331243A5041544624 @default.
- W2137331243 hasAuthorship W2137331243A5077466227 @default.
- W2137331243 hasAuthorship W2137331243A5081845117 @default.
- W2137331243 hasAuthorship W2137331243A5085481487 @default.
- W2137331243 hasAuthorship W2137331243A5086266747 @default.
- W2137331243 hasAuthorship W2137331243A5090217514 @default.
- W2137331243 hasBestOaLocation W21373312431 @default.
- W2137331243 hasConcept C142724271 @default.
- W2137331243 hasConcept C150903083 @default.
- W2137331243 hasConcept C185592680 @default.
- W2137331243 hasConcept C190283241 @default.
- W2137331243 hasConcept C207001950 @default.
- W2137331243 hasConcept C2989005 @default.
- W2137331243 hasConcept C502942594 @default.
- W2137331243 hasConcept C53227056 @default.
- W2137331243 hasConcept C55493867 @default.
- W2137331243 hasConcept C71924100 @default.
- W2137331243 hasConcept C86803240 @default.
- W2137331243 hasConceptScore W2137331243C142724271 @default.
- W2137331243 hasConceptScore W2137331243C150903083 @default.
- W2137331243 hasConceptScore W2137331243C185592680 @default.
- W2137331243 hasConceptScore W2137331243C190283241 @default.
- W2137331243 hasConceptScore W2137331243C207001950 @default.
- W2137331243 hasConceptScore W2137331243C2989005 @default.
- W2137331243 hasConceptScore W2137331243C502942594 @default.
- W2137331243 hasConceptScore W2137331243C53227056 @default.
- W2137331243 hasConceptScore W2137331243C55493867 @default.
- W2137331243 hasConceptScore W2137331243C71924100 @default.
- W2137331243 hasConceptScore W2137331243C86803240 @default.
- W2137331243 hasLocation W21373312431 @default.
- W2137331243 hasLocation W21373312432 @default.
- W2137331243 hasOpenAccess W2137331243 @default.
- W2137331243 hasPrimaryLocation W21373312431 @default.
- W2137331243 hasRelatedWork W134818922 @default.
- W2137331243 hasRelatedWork W1535002852 @default.
- W2137331243 hasRelatedWork W1630761673 @default.
- W2137331243 hasRelatedWork W1841099031 @default.
- W2137331243 hasRelatedWork W1989752693 @default.
- W2137331243 hasRelatedWork W2015720216 @default.
- W2137331243 hasRelatedWork W2087454200 @default.
- W2137331243 hasRelatedWork W2141653687 @default.
- W2137331243 hasRelatedWork W2225312107 @default.
- W2137331243 hasRelatedWork W2276349199 @default.
- W2137331243 hasRelatedWork W2334141684 @default.
- W2137331243 hasRelatedWork W2530907197 @default.
- W2137331243 hasRelatedWork W2567449807 @default.
- W2137331243 hasRelatedWork W2585996719 @default.
- W2137331243 hasRelatedWork W2803758687 @default.
- W2137331243 hasRelatedWork W2885067750 @default.
- W2137331243 hasRelatedWork W3046333564 @default.
- W2137331243 hasRelatedWork W3048165201 @default.
- W2137331243 hasRelatedWork W3069452119 @default.
- W2137331243 hasRelatedWork W3088543617 @default.
- W2137331243 isParatext "false" @default.
- W2137331243 isRetracted "false" @default.
- W2137331243 magId "2137331243" @default.
- W2137331243 workType "article" @default.